Harrow, Inc. completed its acquisition of Melt Pharmaceuticals, Inc. on 2025-11-17, according to the Form 8-K Harrow, Inc. filed with the SEC on 2025-11-18. The filing states a price of $4.3 million.
| Acquirer | Harrow, Inc. |
|---|---|
| Acquired | Melt Pharmaceuticals, Inc. |
| Completed | 2025-11-17 |
| Price stated in the filing | $4.3 million |
| Reported by | Harrow, Inc. (HROW), the buyer |
| Filing | Form 8-K, filed 2025-11-18 |
Want the whole picture on Harrow, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Harrow, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Harrow, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What the filing says
On November 17, 2025, Harrow, Inc. (the "Company") completed the previously announced acquisition of Melt Pharmaceuticals, Inc. ("Melt") pursuant to the Agreement and Plan of Merger, dated September 24, 2025 (the "Merger Agreement"), by and among the Company, Harrow Acquisition Sub, Inc., Melt, and the stockholder representative.
The price, in the filing's words
At closing, the Company paid approximately $4.3 million in cash as initial consideration for the remaining equity interests of Melt.
More from the filing
The contingent regulatory and commercial milestone payments described in the Company's September 26, 2025 Form 8-K remain unchanged.
All closing conditions under the Merger Agreement were satisfied or waived, and the merger became effective on November 17, 2025.
Quoted from Harrow, Inc.'s Form 8-K.
This is the only completed acquisition Harrow, Inc. reported under Item 2.01 in the last twelve months.
Who runs it now, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Harrow, Inc.Look up Harrow, Inc. and see what is on record before you decide.
Get the free SnapshotWhere this comes from
A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.
Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.